52 items matching your search terms.
-
MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer
- Portman, N.; Chen, J.; Lim, E.
-
Frontiers in Oncology
11
:777867,
2021
10.3389/fonc.2021.777867
-
Heart Failure Therapies for the Prevention of HER2-Monoclonal Antibody-Mediated Cardiotoxicity: A Systematic Review and Meta-Analysis of Randomized Trials
- Brown, L. J.; Meredith, T.; Yu, J.; Patel, A.; Neal, B.; Arnott, C.; Lim, E.
-
Cancers (Basel)
13
(21)
:5527,
2021
10.3390/cancers13215527
-
Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic
- Kumar, S.; Freelander, A.; Lim, E.
-
Cancers
13
(19)
:4972,
2021
10.3390/cancers13194972
-
The management of HER2-positive early breast cancer: Current and future therapies
- Chen, J.; Colosimo, M.; Lim, E.
-
Asia Pacific Journal of Clinical Oncology
17 Suppl 6
:3-12,
2021
10.1111/ajco.13655
-
A single-cell and spatially resolved atlas of human breast cancers
- Wu, S. Z.; Al-Eryani, G.; Roden, D. L.; Junankar, S.; Harvey, K.; Andersson, A.; Thennavan, A.; Wang, C.; Torpy, J. R.; Bartonicek, N.; Wang, T.; Larsson, L.; Kaczorowski, D.; Weisenfeld, N. I.; Uytingco, C. R.; Chew, J. G.; Bent, Z. W.; Chan, C. L.; Gnanasambandapillai, V.; Dutertre, C. A.; Gluch, L.; Hui, M. N.; Beith, J.; Parker, A.; Robbins, E.; Segara, D.; Cooper, C.; Mak, C.; Chan, B.; Warrier, S.; Ginhoux, F.; Millar, E.; Powell, J. E.; Williams, S. R.; Liu, X. S.; O'Toole, S.; Lim, E.; Lundeberg, J.; Perou, C. M.; Swarbrick, A.
-
NATURE GENETICS
53
(9)
:1334-1347,
2021
10.1038/s41588-021-00911-1
-
DNA methylation is required to maintain both DNA replication timing precision and 3D genome organization integrity
- Du, Q.; Smith, G. C.; Luu, P. L.; Ferguson, J. M.; Armstrong, N. J.; Caldon, C. E.; Campbell, E. M.; Nair, S. S.; Zotenko, E.; Gould, C. M.; Buckley, M.; Chia, K. M.; Portman, N.; Lim, E.; Kaczorowski, D.; Chan, C. L.; Barton, K.; Deveson, I. W.; Smith, M. A.; Powell, J. E.; Skvortsova, K.; Stirzaker, C.; Achinger-Kawecka, J.; Clark, S. J.
-
Cell Reports
36
(12)
:109722,
2021
10.1016/j.celrep.2021.109722
-
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
- Alves, C. L.; Ehmsen, S.; Terp, M. G.; Portman, N.; Tuttolomondo, M.; Gammelgaard, O. L.; Hundebol, M. F.; Kaminska, K.; Johansen, L. E.; Bak, M.; Honeth, G.; Bosch, A.; Lim, E.; Ditzel, H. J.
-
Nature Communications
12
(1)
:5112,
2021
10.1038/s41467-021-25422-9
-
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition
- Aziz, D.; Portman, N.; Fernandez, K. J.; Lee, C.; Alexandrou, S.; Llop-Guevara, A.; Phan, Z.; Yong, A.; Wilkinson, A.; Sergio, C. M.; Ferraro, D.; Etemadmoghadam, D.; Bowtell, D. D.; kConFab, Investigators; Serra, V.; Waring, P.; Lim, E.; Caldon, C. E.
-
NPJ Breast Cancer
7
(1)
:111,
2021
10.1038/s41523-021-00312-x
-
Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models
- Chew, N. J.; Lim Kam Sian, T. C. C.; Nguyen, E. V.; Shin, S. Y.; Yang, J.; Hui, M. N.; Deng, N.; McLean, C. A.; Welm, A. L.; Lim, E.; Gregory, P.; Nottle, T.; Lang, T.; Vereker, M.; Richardson, G.; Kerr, G.; Micati, D.; Jarde, T.; Abud, H. E.; Lee, R. S.; Swarbrick, A.; Daly, R. J.
-
BREAST CANCER RESEARCH
23
(1)
:82,
2021
10.1186/s13058-021-01461-4
-
Case Report: Paclitaxel-Induced Pneumonitis in Early Breast Cancer: A Single Institution Experience and Review
- Ardolino, L.; Lau, B.; Wilson, I.; Chen, J.; Borella, L.; Stone, E.; Lim, E.
-
Frontiers in Oncology
11
:701424,
2021
10.3389/fonc.2021.701424
-
Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis
- Wu, S. Z.; Roden, D. L.; Al-Eryani, G.; Bartonicek, N.; Harvey, K.; Cazet, A. S.; Chan, C. L.; Junankar, S.; Hui, M. N.; Millar, E. A.; Beretov, J.; Horvath, L.; Joshua, A. M.; Stricker, P.; Wilmott, J. S.; Quek, C.; Long, G. V.; Scolyer, R. A.; Yeung, B. Z.; Segara, D.; Mak, C.; Warrier, S.; Powell, J. E.; O'Toole, S.; Lim, E.; Swarbrick, A.
-
Genome Medicine
13
(1)
:81,
2021
10.1186/s13073-021-00885-z
-
Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer
- Freelander, A.; Brown, L. J.; Parker, A.; Segara, D.; Portman, N.; Lau, B.; Lim, E.
-
Genes
12
(2)
2021
10.3390/genes12020285
-
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer
- Hickey, T. E.; Selth, L. A.; Chia, K. M.; Laven-Law, G.; Milioli, H. H.; Roden, D.; Jindal, S.; Hui, M.; Finlay-Schultz, J.; Ebrahimie, E.; Birrell, S. N.; Stelloo, S.; Iggo, R.; Alexandrou, S.; Caldon, C. E.; Abdel-Fatah, T. M.; Ellis, I. O.; Zwart, W.; Palmieri, C.; Sartorius, C. A.; Swarbrick, A.; Lim, E.; Carroll, J. S.; Tilley, W. D.
-
NATURE MEDICINE
27
(2)
:310-320,
2021
10.1038/s41591-020-01168-7
-
CDK4/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of care
- Hui, R.; de Boer, R.; Lim, E.; Yeo, B.; Lynch, J.
-
Asia Pacific Journal of Clinical Oncology
17 Suppl 1
:3-14,
2021
10.1111/ajco.13555
-
Estrogen receptor positive breast cancer patient derived xenograft models in translational research.
- Chia, K.; Freelander, A.; Kumar, S.; Parker, A.; Segara, D.; Portman, N.; Lim, E.
-
Current Opinion in Endocrine and Metabolic Research
15
:31-36,
2020
-
Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer
- de Boer, R.; Hui, R.; Lim, E.; Yeo, B.; Zdenkowski, N.
-
Asia-Pacific Journal of Clinical Oncology
16 Suppl 5
:3-14,
2020
10.1111/ajco.13461